# Amino acid restriction sensitizes lung cancer cells to ferroptosis via GCN2-dependent activation of the integrated stress response

**Authors:** Viktor Antonsson Garellick, Nadia Gul, Parvin Horrieh, Dyar Mustafa, Angana A.H. Patel, Martin Dankis, Samantha W. Alvarez, Johanna Berndtson, Saeed Mahdavi, Maria Schwarz, Andreas Persson, Fikret Zahirovic, Clotilde Wiel, Volkan I. Sayin, Per Lindahl

PMC · DOI: 10.1016/j.redox.2025.103988 · 2025-12-24

## TL;DR

Restricting certain amino acids makes lung cancer cells more vulnerable to a type of cell death called ferroptosis, potentially improving cancer treatment.

## Contribution

The study reveals that amino acid restriction enhances ferroptosis sensitivity in lung cancer cells via GCN2 and the integrated stress response.

## Key findings

- Reduced amino acids (excluding cysteine) increase BSO sensitivity in lung cancer cells.
- GCN2 and the integrated stress response promote lipid peroxidation under glutathione depletion.
- Amino acid restriction could be combined with ferroptosis-inducing agents for cancer therapy.

## Abstract

Lung cancer cells are vulnerable to iron-dependent oxidation of phospholipids leading to ferroptosis, a process countered by glutathione peroxidase-4 that converts lipid hydroperoxides to lipid alcohols using glutathione as reducing agent. Since ferroptosis-inducing agents are in clinical development, identifying modifiers of ferroptosis susceptibility is warranted. Here, we investigate the impact of amino acids on susceptibility to buthionine sulfoximine (BSO), a glutamate-cysteine ligase inhibitor that blocks biosynthesis of glutathione. We found that reduced amounts of amino acids other than cysteine increased the sensitivity to BSO and other ferroptosis-inducing agents, in a panel of mouse and human lung cancer cells, without affecting glutathione production. Activation of the amino acid sensor protein GCN2 and the integrated stress response lowered the threshold for lipid peroxidation by promoting ATF4-dependent mitochondrial respiration and reactive oxygen species leakage from the electron transport chain under glutathione depletion. The finding provides new insights into lung cancer metabolism and raises the possibility of using amino acid restricted diets in combination with ferroptosis-inducing agents as cancer therapies.

## Linked entities

- **Genes:** EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) [NCBI Gene 440275], ATF4 (activating transcription factor 4) [NCBI Gene 468], GPX4 (glutathione peroxidase 4) [NCBI Gene 819427]
- **Proteins:** GPX4 (glutathione peroxidase 4), EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4)
- **Chemicals:** buthionine sulfoximine (PubChem CID 21157), glutathione (PubChem CID 124886)
- **Diseases:** lung cancer (MONDO:0005138)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Tnfrsf1b (tumor necrosis factor receptor superfamily, member 1b) [NCBI Gene 21938] {aka CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, EIF2A (eukaryotic translation initiation factor 2A) [NCBI Gene 83939] {aka CDA02, EIF-2A, MST089, MSTP004, MSTP089}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, RPS6 (ribosomal protein S6) [NCBI Gene 6194] {aka S6, eS6}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) [NCBI Gene 19766] {aka D330015H01Rik, RIP, RIP-1, Rinp, Rip1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Eif2ak4 (eukaryotic translation initiation factor 2 alpha kinase 4) [NCBI Gene 27103] {aka 2610011M03, GCN2, MGCN2}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1) [NCBI Gene 79094], EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, Ddit3 (DNA-damage inducible transcript 3) [NCBI Gene 13198] {aka AltDDIT3, CHOP-10, CHOP10, chop, gadd153}, Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, ASNS (asparagine synthetase (glutamine-hydrolyzing)) [NCBI Gene 440] {aka ASNSD, TS11}, CTRL (chymotrypsin like) [NCBI Gene 1506] {aka CTRL1}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, SCAF1 (SR-related CTD associated factor 1) [NCBI Gene 58506] {aka SRA1}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, EIF2AK1 (eukaryotic translation initiation factor 2 alpha kinase 1) [NCBI Gene 27102] {aka HCR, HRI, hHRI}, Gclc (glutamate-cysteine ligase, catalytic subunit) [NCBI Gene 14629] {aka D9Wsu168e, GLCL-H, Ggcs-hs, Glclc}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, Eif2ak2 (eukaryotic translation initiation factor 2-alpha kinase 2) [NCBI Gene 19106] {aka 2310047A08Rik, 4732414G15Rik, Pkr, Prkr, Tik}, EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) [NCBI Gene 440275] {aka GCN2, PVOD2}, PPP1R15A (protein phosphatase 1 regulatory subunit 15A) [NCBI Gene 23645] {aka GADD34}, Ppp1r15a (protein phosphatase 1, regulatory subunit 15A) [NCBI Gene 17872] {aka 9630030H21, Gadd34, Myd116}, HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320] {aka EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Chac1 (ChaC, cation transport regulator 1) [NCBI Gene 69065] {aka 1810008K03Rik}, Eif4ebp1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 13685] {aka 4e-bp1, PHAS-I}, GCLC (glutamate-cysteine ligase catalytic subunit) [NCBI Gene 2729] {aka CNSHA7, GCL, GCS, GLCL, GLCLC}, EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) [NCBI Gene 5610] {aka PKR, PPP1R83, PRKR}, Tlr3 (toll-like receptor 3) [NCBI Gene 142980]
- **Diseases:** skin cancer (MESH:D012878), glioma (MESH:D005910), lung injury (MESH:D055370), neuroblastoma (MESH:D009447), Tumor (MESH:D009369), triple (MESH:C536008), Lung cancer (MESH:D008175), lymphomas (MESH:D008223), intestinal tumors (MESH:D007414), toxicity (MESH:D064420), metastasis (MESH:D009362), virus infection (MESH:D014777), asbestosis (MESH:D001195), hypoxia (MESH:D000860), inflammatory (MESH:D007249), ISR (MESH:D000079225), breast cancer (MESH:D001943)
- **Chemicals:** Lipid (MESH:D008055), Glutathione (MESH:D005978), 7-AAD (MESH:C025942), superoxide (MESH:D013481), ChlQ (MESH:D002738), MT (MESH:C555916), auranofin (MESH:D001310), glutamate (MESH:D018698), etoposide (MESH:D005047), formaldehyde (MESH:D005557), phenol red (MESH:D010637), Menadione (MESH:D024483), SDS (MESH:D012967), BSO (MESH:D019328), glucose (MESH:D005947), methanol (MESH:D000432), leucine (MESH:D007930), norvaline (MESH:C005313), Amino acid (MESH:D000596), bafilomycin A1 (MESH:C040929), necrostatin-1 (MESH:C507699), Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (MESH:C108897), BODIPY-C11 (-), methionine (MESH:D008715), luciferin (MESH:D000090562), glutamine (MESH:D005973), TBS-T (MESH:C027647), Cysteine (MESH:D003545), MitoSox Red (MESH:C000597839), DFO (MESH:D003676), pyridine (MESH:C023666), puromycin (MESH:D011691), Iron (MESH:D007501), glycine (MESH:D005998), FCCP (MESH:D002259), gentamicin (MESH:D005839), lipid hydroperoxides (MESH:D008054), penicillin (MESH:D010406), LIP (MESH:C000595890), essential amino acids (MESH:D000601), certolizumab (MESH:D000068582), isoleucine (MESH:D007532), streptomycin (MESH:D013307), Z-VAD-FMK (MESH:C096713), Urea (MESH:D014508), cystine (MESH:D003553), MitoSox (MESH:C521281), Ser (MESH:D012694), F12 (MESH:C007782), Oxygen (MESH:D010100), erastin (MESH:C477224), Prooxidant (MESH:D017382), Rot (MESH:D012402), Oligo (MESH:D009840), Helium (MESH:D006371), acetic acid (MESH:D019342), ATP (MESH:D000255), PBS (MESH:D007854), Lipofectamine (MESH:C086724), phospholipids (MESH:D010743)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C at 20, F12, serine/threonine, C with 5, glutamate-cysteine, serine to cysteine, C at 3
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), SKNBE-2 — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0528), F12AA — Homo sapiens (Human), Colorectal adenoma, Cancer cell line (CVCL_B261), F12 — Mus musculus (Mouse), Hybridoma (CVCL_M045), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), H460 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0459), MC38 — Mus musculus (Mouse), Mouse colon adenocarcinoma, Cancer cell line (CVCL_B288), H23 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_1547), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), 1C — Pan troglodytes (Chimpanzee), Induced pluripotent stem cell (CVCL_1G30), PanO2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), RPMI — Homo sapiens (Human), Plasma cell myeloma, Cancer cell line (CVCL_0014), Hepa1-6 — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_0327), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), H838 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_1594), HT-1080 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_0317), KP — Homo sapiens (Human), Renal pelvis carcinoma, Cancer cell line (CVCL_A1IF)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12828773/full.md

---
Source: https://tomesphere.com/paper/PMC12828773